255
Participants
Start Date
September 28, 2020
Primary Completion Date
June 10, 2024
Study Completion Date
June 10, 2024
GT005
GT005 is a recombinant, non-replicating AAV2 expressing human complement factor I (CFI). GT005 was administered as a single time subretinal injection into the study eye of subjects allocated to one of the two GT005 doses.
Sydney Hospital and Sydney Eye Hospital, Sydney
The University of Melbourne - The Centre for Eye Research Australia (CERA), Melbourne E.
Columbia University Medical Center, New York
Centre Paradis Monticelli, Marseille
Retina Associates of Western New York, Rochester
Erie Retinal Surgery ,INC, Erie
Mid Atlantic Retina - Wills Eye Hospital, Philadelphia
CHU Dijon - Hopital Mitterrand, Dijon
The Retina Care Center, Baltimore
Universitaetsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck
Duke Eye Center, Durham
Clinica Baviera, Madrid
Palmetto Retina Center, West Columbia
Georgia Retina PC, Marietta
Southeast Retina Center, Augusta
Clinica Universidad de Navarra - Pamplona, Pamplona
VitreoRetinal Associates, P.A., Gainesville
Rand Eye Institute, Deerfield Beach
Bascom Palmer Eye Institute, Miami
Retina Vitreous Associates of Florida, St. Petersburg
Southeastern Retina Associates, PC, Knoxville
Charles Retina Institute, Germantown
Internationale Innovative Ophthalmochirurgie, Düsseldorf
CHU de Nantes - Hôtel-Dieu, Nantes
Cleveland Clinic, Cleveland
Cincinnati Eye Institute, Cincinnati
Midwest Eye Institute Northside, Indianapolis
Associated Retinal Consultants PC, Royal Oak
Retina Associates of Michigan, Grand Blanc
Wolfe Eye Clinic, West Des Moines
Universitätsklinikum Bonn, Bonn
University Retina Macula Associates PC, Lemont
Illinois Retina Associates, Chicago
Retina Associates, LLC, Shawnee Mission
Universitaetsklinikum Tuebingen, Tübingen
Retina Foundation of the Southwest, Dallas
Texas Retina Associates (Dallas), Dallas
Retina Consultants of Houston, The Woodlands
Retina Consultants of Houston-TMC, Bellaire
Retinal Consultants of San Antonio, San Antonio
Austin Research Center for Retina, PLLC, Austin
Southwest Retina Research Center, Durango
Rocky Mountain Retina Consultants, Salt Lake City
Retinal Research Institute (retina consultants of AZ), Phoenix
Sierra Eye Associates, Reno
Retina Vitreous Associates Medical Group, Beverly Hills
Retina Consultants of San Diego, Poway
Retina Consultants of Orange County, Fullerton
Northern California Retina Vitreous Associates, Mountain View
Byers Eye Institute at Stanford, Palo Alto
University of California (UC) Davis Medical Group Eye Center, Sacramento
Casey Eye Institute - OHSU, Portland
Oregon Retina, Eugene
Retina Center Northwest, Silverdale
Ophthalamic Consultants of Boston (OCB), Boston
Department of Ophthalmology UW Medicine, Seattle
Oftalmika Spolka z ograniczona odpowiedzialnoscia, Bydgoszcz
Instituto de microcirugía ocular, Barcelona
Moorfields Eye Hospital - NHS Foundation Trust, London
Retina Clinic London, London
John Radcliffe Hospital, Oxford
Sunderland Eye Infirmary, Sunderland
Lead Sponsor
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Gyroscope Therapeutics Limited
INDUSTRY